Login
Home
Charts
Search
Watchlist
Products

Amines & Plasticizers Ltd

AMNPLST·NSE
169.00-0.38%Wed, 23 Sept '26 15:53

Amines & Plasticizers Ltd

AMNPLST
NSE
169.00
-0.38%
|Wed, 23 Sept '26 15:53
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
924Cr
Close
Close Price
168.00
Industry
Industry
Speciality Chemicals
PE
Price To Earnings
23.97
PS
Price To Sales
1.59
Revenue
Revenue
581Cr
Rev Gr TTM
Revenue Growth TTM
-12.40%
PAT Gr TTM
PAT Growth TTM
-3.04%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
157175177137167191166140133142155151
Growth YoY
Revenue Growth YoY%
19.89.16.30.35.98.8-6.52.0-20.1-25.3-6.47.3
Expenses
ExpensesCr
141158155123150174145127122130132136
Operating Profit
Operating ProfitCr
161722151617211311132315
OPM
OPM%
10.19.712.410.89.88.912.79.38.18.815.19.9
Other Income
Other IncomeCr
110000000000
Interest Expense
Interest ExpenseCr
433223321121
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
12131712131317108112113
Tax
TaxCr
345333432353
PAT
PATCr
910139101013768159
Growth YoY
PAT Growth YoY%
151.8100.851.49.37.6-1.2-1.0-14.2-36.9-22.319.827.5
NPM
NPM%
5.85.67.36.35.95.17.75.34.65.39.96.3
EPS
EPS
1.61.82.41.61.81.82.31.41.11.42.81.7
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
157175177137167191166140133142155151
Growth YoY
Revenue Growth YoY%
19.89.16.30.35.98.8-6.52.0-20.1-25.3-6.47.3
Expenses
ExpensesCr
141158155123150174145127122130132136
Operating Profit
Operating ProfitCr
161722151617211311132315
OPM
OPM%
10.19.712.410.89.88.912.79.38.18.815.19.9
Other Income
Other IncomeCr
110000000000
Interest Expense
Interest ExpenseCr
433223321121
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
12131712131317108112113
Tax
TaxCr
345333432353
PAT
PATCr
910139101013768159
Growth YoY
PAT Growth YoY%
151.8100.851.49.37.6-1.2-1.0-14.2-36.9-22.319.827.5
NPM
NPM%
5.85.67.36.35.95.17.75.34.65.39.96.3
EPS
EPS
1.61.82.41.61.81.82.31.41.11.42.81.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
262295326455399442563597647661571581
Growth
Revenue Growth%
-13.112.510.739.4-12.310.727.46.18.32.1-13.6-12.4
Expenses
ExpensesCr
239267298421357389523555578592511520
Operating Profit
Operating ProfitCr
232828344253404269696062
OPM
OPM%
8.99.68.77.410.411.97.17.110.710.410.510.6
Other Income
Other IncomeCr
014315533111
Interest Expense
Interest ExpenseCr
8678910910131055
Depreciation
DepreciationCr
223334455666
PBT
PBTCr
142123263044323054554952
Tax
TaxCr
56896118714141314
PAT
PATCr
91515162533242340413739
Growth
PAT Growth%
44.163.6-0.311.349.732.5-26.8-4.174.13.0-10.9-3.0
NPM
NPM%
3.55.04.53.66.27.44.23.86.26.26.46.6
EPS
EPS
1.62.72.73.04.55.94.34.27.27.56.67.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
262295326455399442563597647661571581
Growth
Revenue Growth%
-13.112.510.739.4-12.310.727.46.18.32.1-13.6-12.4
Expenses
ExpensesCr
239267298421357389523555578592511520
Operating Profit
Operating ProfitCr
232828344253404269696062
OPM
OPM%
8.99.68.77.410.411.97.17.110.710.410.510.6
Other Income
Other IncomeCr
014315533111
Interest Expense
Interest ExpenseCr
8678910910131055
Depreciation
DepreciationCr
223334455666
PBT
PBTCr
142123263044323054554952
Tax
TaxCr
56896118714141314
PAT
PATCr
91515162533242340413739
Growth
PAT Growth%
44.163.6-0.311.349.732.5-26.8-4.174.13.0-10.9-3.0
NPM
NPM%
3.55.04.53.66.27.44.23.86.26.26.46.6
EPS
EPS
1.62.72.73.04.55.94.34.27.27.56.67.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1111111111111111111111
Reserves
ReservesCr
3044577197130151172209248281
Current Liabilities
Current LiabilitiesCr
72799213088130115131139138109
Non Current Liabilities
Non Current LiabilitiesCr
2627304035343331312020
Total Liabilities
Total LiabilitiesCr
140161190252232305310344389416422
Current Assets
Current AssetsCr
91106128174149217220256303332342
Non Current Assets
Non Current AssetsCr
4855627883889088868481
Total Assets
Total AssetsCr
140161190252232305310344389416422
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1111111111111111111111
Reserves
ReservesCr
3044577197130151172209248281
Current Liabilities
Current LiabilitiesCr
72799213088130115131139138109
Non Current Liabilities
Non Current LiabilitiesCr
2627304035343331312020
Total Liabilities
Total LiabilitiesCr
140161190252232305310344389416422
Current Assets
Current AssetsCr
91106128174149217220256303332342
Non Current Assets
Non Current AssetsCr
4855627883889088868481
Total Assets
Total AssetsCr
140161190252232305310344389416422

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
141022103144-275472966
Investing Cash Flow
Investing Cash FlowCr
-1-5-4-16-17-6-4-2-1-3-1
Financing Cash Flow
Financing Cash FlowCr
-13-5-1412-226-130-16-20-58
Net Cash Flow
Net Cash FlowCr
-1046-844-4333067
Free Cash Flow
Free Cash FlowCr
124141433-352432666
CFO To PAT
CFO To PAT%
149.964.2146.559.2125.5133.5-111.319.8117.671.1181.8
CFO To EBITDA
CFO To EBITDA%
58.333.576.128.774.082.4-66.110.767.842.2111.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
141022103144-275472966
Investing Cash Flow
Investing Cash FlowCr
-1-5-4-16-17-6-4-2-1-3-1
Financing Cash Flow
Financing Cash FlowCr
-13-5-1412-226-130-16-20-58
Net Cash Flow
Net Cash FlowCr
-1046-844-4333067
Free Cash Flow
Free Cash FlowCr
124141433-352432666
CFO To PAT
CFO To PAT%
149.964.2146.559.2125.5133.5-111.319.8117.671.1181.8
CFO To EBITDA
CFO To EBITDA%
58.333.576.128.774.082.4-66.110.767.842.2111.1

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
922193181831104206013859091,179748924
Price To Earnings
Price To Earnings
10.414.821.611.14.512.925.216.822.828.820.524.0
Price To Sales
Price To Sales
0.30.71.00.40.30.91.10.61.41.81.31.6
Price To Book
Price To Book
2.34.04.72.21.03.03.72.14.14.62.63.2
EV To EBITDA
EV To EBITDA
6.39.712.87.23.98.416.610.813.817.512.114.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
24.427.625.021.725.828.118.418.023.424.223.923.9
OPM
OPM%
8.99.68.77.410.411.97.17.110.710.410.510.6
NPM
NPM%
3.55.04.53.66.27.44.23.86.26.26.46.6
ROCE
ROCE%
21.924.024.721.424.425.017.515.121.919.317.217.2
ROE
ROE%
22.226.721.720.122.823.214.712.518.115.812.512.5
ROA
ROA%
6.59.27.86.510.610.77.76.710.29.88.78.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
922193181831104206013859091,179748924
Price To Earnings
Price To Earnings
10.414.821.611.14.512.925.216.822.828.820.524.0
Price To Sales
Price To Sales
0.30.71.00.40.30.91.10.61.41.81.31.6
Price To Book
Price To Book
2.34.04.72.21.03.03.72.14.14.62.63.2
EV To EBITDA
EV To EBITDA
6.39.712.87.23.98.416.610.813.817.512.114.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
24.427.625.021.725.828.118.418.023.424.223.923.9
OPM
OPM%
8.99.68.77.410.411.97.17.110.710.410.510.6
NPM
NPM%
3.55.04.53.66.27.44.23.86.26.26.46.6
ROCE
ROCE%
21.924.024.721.424.425.017.515.121.919.317.217.2
ROE
ROE%
22.226.721.720.122.823.214.712.518.115.812.512.5
ROA
ROA%
6.59.27.86.510.610.77.76.710.29.88.78.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Amines & Plasticizers Ltd is a speciality chemicals maker whose products are the invisible workhorses inside oil refineries, pharmaceutical plants, textile mills, and electronics factories - the amines and solvents that strip out impurities, catalyse reactions, and make fibres possible. Founded in 1973 as a first-generation venture by Hemant Kumar Ruia, it was the first Indian company to indigenously develop methyl diethanolamine (MDEA), a critical gas-treating solvent, and has since grown into one of the world’s largest producers of N-methyl morpholine oxide (NMMO), serving customers across more than 85 countries. The recurring approach is to build proprietary, hard-to-copy chemical know-how in-house - for every product except ethanolamines, the technology comes from its own R&D - and then sell those molecules globally into industries where switching suppliers is slow and expensive. # Business segments Four chemical engines built on a single manufacturing backbone - a gas-treating franchise that cleans the world’s refineries, an ethanolamine business that dominates its home market, a morpholine platform that enables greener textiles, and a specialty ethoxylates engine feeding everything from cosmetics to electronics - plus a small oilfield-and-engineering division that rounds out the portfolio. ## 1. Gas treating chemicals and specialty solvents: the refinery’s cleaning crew **APL makes the solvents that strip carbon dioxide and hydrogen sulphide out of gas streams in refineries, fertiliser plants, and hydrogen production units - and it was the first Indian company to do so with its own technology.** - **The cornerstone molecule** - MDEA is the base solvent for removing CO₂ and H₂S from process gas, and APL’s indigenously developed version anchors a family of formulated blends sold under the Aminosol brand. - **Custom blends for specific customers** - the company has developed tailor-made solvent formulations for over 25 domestic and international clients, including demulsifiers matched to country-specific crude profiles and carbon-capture formulations for flue gas and cement plants. - **Not just chemicals, but the engineering to use them** - APL sells analytical and process engineering services alongside its solvents, including amine analysis, process simulation software, operator training, and even physical Amine Reclamation Units that extend solvent life inside refineries. - **Hydrogen and carbon capture are the next frontier** - its formulated MDEA already works across Brown, Grey, Blue, and Turquoise hydrogen production, and the company has tied up with a leading Japanese multinational to manufacture new carbon-capture solvents. ## 2. Alkanolamines and alkyl alkanolamines: the domestic champion **APL supplies roughly 70% of India’s ethanolamine demand - the nitrogen-containing alcohols that go into everything from cement additives and water-treatment chemicals to pharmaceutical raw materials.** - **A commanding home-market position** - the company holds a 75-80% domestic market share in ethanolamines and caters to approximately 70% of total Indian demand for ethanolamines and alkyl alkanolamines. - **Products that touch construction and medicine** - two propylene-oxide-based alkyl alkanolamines are used as cement grinding aids in infrastructure, while another product gained prominence as a raw material for COVID-19 treatment drugs. - **Green-chemistry credentials in paints** - two products developed by the company are used in water-borne paints and automobile coatings, replacing environmentally unfriendly solvents. - **The building blocks for multiple industries** - these molecules feed into oil refining, petrochemicals, pharmaceuticals, agrochemicals, and textiles, making them a broad-spectrum intermediate. ## 3. Morpholine and derivatives: the green-textile enabler **APL is among the world’s largest producers of NMMO, the solvent that makes Lyocell fibre possible - a cleaner alternative to viscose that has reshaped the textile industry.** - **The molecule behind a fibre revolution** - NMMO (N-Methylmorpholine N-oxide) is an environment-friendly solvent that dissolves wood pulp to spin Lyocell fibre, replacing the polluting viscose process without environmental harm. - **Global scale in a niche** - the company is recognised among the world’s leading manufacturers of morpholine and its derivatives, and ranks among the largest producers of NMMO globally. - **Pharmaceutical linkages** - one morpholine derivative serves as a key raw material for an immunosuppressant drug, giving the engine exposure to high-value pharma supply chains. - **A natural hedge against raw-material risk** - the company imports morpholine as a raw material but exports morpholine derivatives, so foreign-exchange exposure is largely offset by the export revenue stream. ## 4. EO/PO-based specialty products: the formulation toolkit **Using ethylene oxide and propylene oxide as building blocks, APL makes ethoxylates, polyols, and copolymers that become surfactants, polyurethane systems, and performance additives for a widening set of end markets.** - **Surfactants and emulsifiers** - alcohol ethoxylates, sorbitol ethoxylates, and fatty alcohol propoxylates feed the growing surfactants field, while neem-based agrochemical emulsifiers contribute to green chemistry. - **Polyols for polyurethanes** - glycerol polyol and PPG 4000 are the precursors for polyurethane systems used in foams, coatings, and elastomers. - **High-purity grades for demanding applications** - demand is rising for high-purity versions of cosmetic ingredients, metal-working fluids, drug intermediates, textile auxiliaries, and electronic chemicals, all of which draw on EO/PO chemistry. - **R&D is expanding the range** - the company has commercialised cocoamine-based ethoxylates and glycerin-based propoxylates through in-house R&D, and is designing a range of surfactants based on tridecyl alcohol ethoxylate. ## 5. Oilfield chemicals, industrial gases, and engineering services: the ancillary workshop **A compact division that supplies hydrogen-sulphide scavengers and corrosion inhibitors to upstream oil and gas, plus dissolved acetylene and custom pressure equipment from a separate site at Khopoli.** - **Chemicals for the oil patch** - the portfolio includes H₂S scavengers, acid corrosion inhibitors, flow improvers, pour-point depressants, bactericides, and oil-spill dispersants, with products accepted in international markets. - **A small industrial-gas operation** - the Khopoli plant manufactures dissolved acetylene with a capacity of 2 lakh cubic metres per year, running at roughly 50% utilisation with a team of eight. - **Heavy fabrication on the side** - the engineering services division at the same Khopoli site builds heat exchangers, pressure vessels, and boilers with a capacity of 100 tonnes per month and a team of 80. - **Molecular-sieve distribution** - APL represents one of the world’s biggest molecular-sieve producers and is a major distributor in India, supplying drying agents used in industrial gases, fuel ethanol, and polymer processing. # Manufacturing, technology, and R&D infrastructure **Two integrated plants in Maharashtra, 13 reaction chemistries under one roof, and a DSIR-recognised R&D lab that has commercialised 43 new products in five years - this is the shared backbone that makes every segment possible.** - **Two sites, one chemistry backbone** - the main Turbhe plant in Navi Mumbai sits on 18.11 acres with 32,760 MTPA of installed capacity and runs at 85% utilisation, while the Khopoli site adds another 25.41 acres housing the gases and engineering divisions. - **In-house R&D as the growth engine** - the DSIR-recognised lab has commercialised 43 new products over five years, developed import-substitute molecules for electric-vehicle batteries and hydrogen electrolysers, and created custom solvent formulations for more than 25 customers. - **Self-sufficient engineering** - an in-house engineering division handles plant maintenance and equipment upkeep, reducing reliance on outside contractors and keeping costs down. - **Raw-material strategy built around ethylene oxide** - the single most important feedstock is ethylene oxide, sourced locally because it is too inflammable to import; the company manages price volatility through commercial negotiation and has invested in its own fleet of EO tanks for safer logistics. # Group structure and partners **A lean structure centred on a single listed entity with one overseas subsidiary in the UAE, a 26% stake in a captive solar-power venture, and technology partnerships with American and Japanese multinationals.** - **The UAE subsidiary** - wholly owned Amines and Plasticizers FZ-LLC in the Ras Al Khaimah Free Trade Zone trades in the company’s products and those of other manufacturers, giving APL a foothold in Middle Eastern markets. - **Captive solar power** - a 26% stake in Radiance MH Sunrise Six Private Limited was taken as a regulatory pre-condition to secure a 2.6 MW ground-mounted solar plant that supplies concessional green power to the company’s operations. - **Global technology tie-ups** - the company has memoranda of understanding with leading American and Japanese corporations for customised product development, including a tie-up with a Japanese multinational for manufacturing new carbon-capture solvents. - **Promoter-led governance** - the board is chaired by founder Hemant Kumar Ruia (over four decades of experience) alongside his son Yashvardhan Ruia as Executive Director; the company is listed on both BSE and NSE.

Documents — Amines & Plasticizers Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/j4u3cudr2h5bsnr623lt6w2z.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/hjx6v5pbxk1rf40okiaxg0f4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/pf6xi9ij7csrm3cl0pxta7c1.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/d0waoz31088yhdjxjteqekjt.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/3ut213rbfqcgbjv0u0f7w5e2.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/0y8pobl0dhz15wn0rr0nyp6r.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/z2bp2f6a46qm68n9l94duk2v.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/bt84ndhzo1nrahcocgc19b94.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/2j3yr4bydjxnjmrql4nshrl9.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/m8li030ldhnmnsinplgxanv2.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/404xa0rze3kle50kavbuy3bg.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/0e79f141o8w6yzbeb9xxl1xp.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/ts8uww8907gcoxqldc4i6de0.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/4f331jrqi0k5kmo1f5fff1pf.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/1mbuioegt9mffh3cmpaqijwi.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/bxle9mnhrx0dzj361zo34ocy.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/wbfkd4pse116d7krm6wh3tx2.pdf